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Radiochromic films comprised of lithium-10,12-pentacosa diynoate (LiPCDA) crystals, a form of 
diacetylene, have been developed for in vivo real-time dosimetry. The polymerization of LiPCDA 
results in a change in optical density that is related to the absorbed dose. The dose response of 
diacetylene monomers is dependent on their packing, determined by the R groups. LiPCDA used 
in commercial film can have two distinct dose sensitive forms, 635LiPCDA and 674LiPCDA, with 
peak absorbances occurring at 635 nm and 674 nm, respectively. While the two forms do not differ 
in their R groups, they have different dosimetric behaviours. The 674LiPCDA achieved through 
desiccation of 635LiPCDA was 3-fold less sensitive to dose and had ~7-fold higher dynamic range. 
This indicates that the dosimetric behaviour of radiochromic crystals is primarily dependent on 
structure, controlled by more than just the chemical composition of individual monomers as water 
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1.1 Radiotherapy and dosimetry 
It was estimated by the Canadian Cancer Society that there would be 225,800 new cancer 
patients in 20201 with approximately 50% of patients receiving radiation therapy during the course 
of illness2. During a radiotherapy procedure, ionizing radiation is administered either internally 
(known as brachytherapy) by implanting a radioactive isotope emitting gamma or beta rays, or 
externally (known as external beam) with high energy X-rays or electron beams delivered with a 
clinical linear accelerator (LINAC). High energy photons (X-rays or γ-rays) are used to indirectly 
ionize deoxyribonucleic acid (DNA), disrupting the genes of cancerous cells, which either destroys 
the cell or prevents cellular mitosis3–5. Irradiated healthy tissue may also be damaged as exposure 
of healthy tissue to radiation is unavoidable6. For this reason, radiation is delivered in segments, 
known as fractions, over a few days7 or weeks4 to allow for partial repair of normal cells.  
The absorbed energy per unit mass of material due to ionizing radiation exposure is referred 
to as dose, measured in units of Gy (Gy = 1 J/kg)8. Dosimetry is the measurement and analysis of 
absorbed dose by a living organism or substance.  A typical radiotherapy prescription in external 
beam is characterized by the total dose to the tumour. However, dose distribution, and not just 
prescribed dose, is important for tumour control and limiting radiation related side effects.  Prior 
to treatment, a radiotherapy treatment plan with three-dimensional dose distribution is developed.  
To ensure patients safely receive their prescribed dose, pre-treatment quality assurance (QA) 
dosimetric tests9,10 are performed on tissue mimicking phantoms that have a similar dose response 
to water. These phantoms are irradiated and the dose response is measured against the expected 
dose to ensure that the treatment is deliverable according to the plan criteria11. Pre-treatment QA 
is the current standard procedure for most radiotherapy clinics, but it does not provide information 




Recent treatment techniques have been impacted by advances in radiotherapy technologies. 
Strategies have shifted towards plans that deliver higher doses of radiation with lower fractions. 
High dose plans are made possible with technologies such as volumetric modulated arc therapy14 
and intensity-modulated radiation therapy15,16 as well as image guidance16. This is because they 
allow for tighter margins around the target and conformal dose distribution to the target volume18,19  
while reducing the dose to surrounding organs at risk (Figure 1).  
 
Figure 1: Examples of dose distribution using 3DCRT: 3-dimensional conformal radiotherapy, IMRT: 
intensity modulated radiotherapy and VMAT: volumetric modulated arc therapy. The red area represents 
the high dose region and the dark blue surface the low dose region. Vanneste et.al20 
However, the complexity and number of moving components involved in these treatments 
leave them vulnerable to many sources of error compounded on top of setup errors, changes in 
anatomy, patient motion, or motion of the inner organs21. Many of these factors have been studied 
independently, but the errors are able to combine to a larger effect on treatment not observed during 
independent measures. Therefore, it was recommended by the International Atomic Energy 
Agency to perform in vivo dosimetry for all groups of patients undergoing radiotherapy22. Thus, 




1.2 In vivo dosimetry  
 In radiation therapy, in vivo dosimetry is the measurement of radiation dose absorbed by 
the patient during treatment. This can be done by temporarily placing a dosimeter into the patient 
through a catheter or an orifice, or by placing it on the skin23. In vivo dosimetry provides an 
independent verification of the treatment procedure to identify errors in dose distribution 
calculations, machine calibration and patient setup23,24. Thus, it is recommended by several 
national and international agencies22,25 that in vivo dose measurements should be made for every 
patient receiving radiotherapy. However, in vivo dosimetry is not a regular component of 
radiotherapy due to the additional cost and human resources needed26.   
For a dosimeter to be considered ideal for routine real-time in vivo dosimetry it has to meet 
the set of key requirements established by Rink et al.27,28 It must be small enough to not shift tissue 
and should have an effective atomic number (Zeff = 7.26
29) similar to that of water in order to 
undergo similar interactions with ionizing radiation so as to not perturb dose distribution around 
it.  It needs to have small volume over which dose is measured so as to not be susceptible to volume 
averaging in an area where dose distribution changes rapidly (known as high dose gradient, e.g. 
6% drop per mm in brachytherapy type treatments), while being sensitive enough with sufficient 
signal to noise to measure dose down to 0.01 Gy. The dosimetric response should be acquired in 
real-time for intervention and correction during treatment. A full list of requirements is shown in 
Table 1. Some current commercially available dosimeters such as semiconductor silicon diode 
arrays, metal-oxide semiconductor field effect transistors, ion chambers and thermally/optically 
stimulated diodes have been adapted for in vivo dosimetry. However, these technologies have 




calibration27,31 that preclude them for routine in vivo dose measures. Radiochromic film dosimeters 
have been suggested as a candidate that fulfills most of the aforementioned requirements28,32.  
Table 1: List of criteria for an ideal in vivo point based real-time dosimeter. Table recreated with 
permission. Rink et al28, *Duterix et.al33  
Criterion No. Criterion Comments 
1 Small size (<1mm3) 
Does not physically perturb tissue and effect 
delivered dose to surrounding tissue; can 
measure point dose at interfaces between 
tissues of varying densities and composition; 
used on steep part of dose–depth curve or in the 




Near water-equivalent* (difference 
<10%) (response independent of energy) 
Does not alter dose distribution to tissue (tissue 
assumed to be similar to water) * own reading 
converted to dose delivered to water (and/or 
tissue); does not cause artifacts during low 
energy image guided radiotherapy   
 
3 
Fast kinetics and stable response 
(interrogation process dose not induce 
false signal) 
 
Both required for real-time readout of dose 
 
4 
Signal ∝ dose in 1-1000cGy range 
(linear within 2%) 
Simplicity of conversion from measurements to 
dose; no need to track delivered dose to-date; 
simple function is acceptable in lieu of linearity 
 
5 Dose resolution (down to cGy) 
Measurements of doses down to a few cGy with 




Dose-rate independence (10-1000 
cGy/min) 
(no statistical difference using α = 0.05) 
No need for prior knowledge of dose; 




Insensitive to environmental conditions 
(<2% variation over clinical temperature 
range 20-38°C) 
Temperature, humidity, and light insensitivity 




Requirements of dosimeter embodiments are 






1.3 Radiochromic film dosimetry  
Radiochromic films are optical dosimeters that change in colour and increase in optical 
density when exposed to ionizing radiation34. Some radiochromic films, such as GafChromic® 
EBT-3 and MD-55 (Ashland, Bridgewater, NJ, USA) used for dosimetry, are composed of one or 
more sensor layers of radiochromic crystals suspended within a binder matrix such as gelatin35,36. 
The monomers composing the radiochromic crystals undergo polymerization when exposed to 
ionizing radiation without the need for chemical processing34.  
Commercial radiochromic films are typically used to measure two-dimensional dose 
distributions34,37. Because of their high spatial resolution, low energy dependence and near tissue 
equivalence (Zeff  = 7.26
29),  they are suitable for dose measurement in high dose gradients34. Dose 
measurements are typically performed 3-24 hours after exposure38,39 due to polymerization taking 
place even after the end of exposure27. However, it was demonstrated by Rink et al. that 
radiochromic film dosimeters such as MD-55 and EBT (predecessor to EBT-3 with the same active 
component) can be used to measure dose in real time and in vivo28,32 using a fiber-optic read-out 
and a spectrophotometer for measurements. The ∆OD measured during and at the end of exposure 
was still a predictable function of dose28, and the post-exposure continuation of polymerization 
contributed minimal (~1%) uncertainty over clinically relevant doses and dose rates40. These 
advancements make radiochromic film dosimeters a strong candidate for real time in vivo 
dosimetry.  
1.4 Background on radiochromic materials  
 The active component in radiochromic films intended for dosimetric purposes such as 
Gafchromic® EBT-3 and MD-55 (Ashland, Bridgewater, NJ, USA) is lithium-10,12-pentacosa 




chemical structure of both monomer units. These molecules are disubstituted diacetylene 
monomers with two side groups R1 and R2
28,36,42. In the case of PCDA and LiPCDA, the R1 group 
is a long carbon chain and the R2 group has a carboxylate end group which is associated with either 
a H+ or a Li+.  
 
Figure 2: Chemical structure of monomeric PCDA (a) and LiPCDA (b) 
Diacetylene monomers can self-pack into crystal structures43 dependent on the size and 
composition of the side groups36. They can undergo topochemical polymerization44–47, where the 
polymerization occurs only along one axis of the crystal. When exposed to ionizing radiation such 
as UV, X-rays and γ-rays the diacetylene monomers photopolymerize as a solid-state topotactic 
1,4-addition reaction46,48–50 first documented by Wegner in 196941,46,48.  The 1,4-addition reaction 
occurs due to radical formation when ionizing radiation is absorbed by the diacetylene monomer45. 
The mechanism responsible for the topochemical polymerization of disubstituted diacetylenes is 
known as the “turnstile” mechanism47,52. In the turnstile mechanism, diacetylene monomers pivot 




monomers approximately39 1 Å as the new bond is formed47,52. A schematic diagram of the 
monomer stacking, and polymerization are shown in Figure 3. 
 
Figure 3: Schematic representation of the 1,4 topochemical addition reaction, the blue lines indicate the 
axis of polymerization.  
This photopolymerization reaction leads to the formation of a polydiacetylene with alternating 
double (-ene) and triple (-yne) bonded carbon backbone53. The polymer formation is accompanied 
by a visible colour change, resulting in a change in absorbance (∆A) which can be related back to 
the absorbed dose. The polymer formed has a deep color due to the lowest π electron transition of 
the conjugated polymer backbone54. As the ratio of polymer to monomer increases, the absorbance 
also increases28,55. Initially the polymer arrangement is constrained by the surrounding monomer 
matrix.  As the polymer fraction increases the strain on the polymer structure due to the monomers 




state28. This lower energy state has a slightly shifted (few nm) absorbance peak relative to the 
constrained polymer28,56,57. In the case where all the monomers are polymerized and there are no 
constraints, the polymer undergoes a complete reorientation, accompanied by an abrupt large shift 
in absorbance peak and the polymer will turn red58. It was described by Enkelmann in 198444 that, 
for adjacent diacetylene monomers to react, they need to be packed in a ladder like configuration 
and within a distance less than or equal to the van der Waals contact distance, ~4 Å of each 
other45,46,54. The packing of monomers depends on the type and size of the end groups on the 
diacetylene48,49. The formed polymer backbone is composed of conjugated monomer units in a 
planar conformation59. The planarity of the backbone is also dependent on the R groups of the 
diacetylene, and the amount of strain applied to this backbone affects the colour of the polymer59. 
The formed polymer chain is shorter than the end-to-end distance of a monomer stack, thus when 
the diacetylene unit at the end of the polymer is too far from the adjacent monomer the reaction 
probability decreases and addition of subsequent monomers to polymer chain slows down and 
eventually terminates. This shortening of the polymer chain and reduced rate of monomer addition 
is the reason absorbance continues to increase even after the termination of irradiation. This post 
irradiation exposure darkening was reported to depend on the total dose delivered60.  
1.5 Recent findings of radiochromic film dosimetry  
The dose response of a given radiochromic film is characterized by the net change in optical 
density (∆ODnet) due to the polymer formation caused by ionizing radiation exposure. However, 
diacetylenes can have different dose response due to variation in packing, as described above.  It 
has been shown that EBT (made of “hair-like” LiPCDA crystals, with an aspect ratio greater than 
with a length to width aspect ratio of 10:154) has an 8-fold increase in dose sensitivity when 




carboxylate end-group54. There are several other ways packing affects the response: location of 
main absorbance peak within the spectrum (λmax), shift in λmax with dose, and post-irradiation 
darkening59.  
MD-55 film (and others, including HD-810, MD-55-2, and HS) is composed of PCDA as 
the sensitive component which has a main absorbance peak (λmax) occurring at 676 nm and a 
shoulder peak at 633 nm28,62. Klassen et al. have reported that PCDA has an linear increase ∆ODnet  
with dose between 0-6 Gy when using the main absorbance peak63. Whereas EBT (including EBT-
2 and EBT-3) films, which use LiPCDA as their dose sensitive component with λmax occurring at 
635 nm and shoulder peak at 583 nm, are non-linear in dose response32,64,65. The dose response of 
these films has also been investigated using wavelengths outside of the main absorbance peak, 
which allowed for measurement of dose up to 100 Gy66. Raman spectroscopy has been used to 
investigate the packing of polydiacetylenes67 and measure absorbed dose68, but is not a practical 
solution for real-time dosimetry given the required instrumentation and complexity for these 
measurements.  
A shift in λmax  to shorter wavelengths was observed for MD-55
56 as the absorbed dose was 
increased. This was not the case for EBT as the λmax is stable with increased dose
32. The percent 
increase in EBT’s post-exposure ∆OD was also found to be nearly two times lower than MD-55 
which may indicate that the polymerization kinetics of LiPCDA are faster than PCDA32. These 
differences are suggested to be due to the packing of the monomers32, where association with the 
Li+ may change the separation distance between the PCDA monomers69. The stability of the main 
absorbance peak and the faster kinetics suggest that the monomers in EBT are more stable 
following a polymerization and that there is no significant change in separation distance between 




Other research groups have also looked at the molecular packing of PCDA through X-ray 
diffraction of PCDA Langmuir-Blodgett films70. It was found that different cations present in the 
subphases could impact the molecular packing and by extension the monomer separation of PCDA 
which was reflected in the X-ray diffraction profiles70. PCDA has also been shown to form 
photoreactive cocrystals which are also radiation sensitive71. The cocrystal variations of PCDA 
showed differences in their translational repeat distance and inter-alkyne distance which were 
accompanied by altered sensitivity to UV irradiation71. These findings show that the radiation 
response of diacetylenes can be influenced by altering the monomer spacing through incorporating 
small molecules in the monomer crystal rather than solely through monomer chemistry.  
It has been shown that LiPCDA crystals can exist in two forms: the “hair-like” structure in 
commercial EBT films (635LiPCDA) and an alternate form with an absorbance peak occurring at 
~674nm 54 (674LiPCDA). The 674LiPCDA form can be achieved by making "plate-like" crystal 
structures of LiPCDA (similar to PCDA) having an aspect ratio of less than 2:1, or through 
desiccation of 635LiPCDA54. The latter was suggested to have resulted in a twisting of the 
conjugated polymer backbone59,72, evidenced by the spectral shift from 635 nm to 674 nm, due to 
the potential change in the packing of the monomers.  This situation is somewhat unique given 
that packing of diacetylene monomer units typically depends on the R1 and R2 end groups which 
were not changed.  
1.6 Hypothesis  
It is hypothesized that the dosimetric behaviour of radiochromic crystals are primarily 
dependent on structure, which may be a function of more than just the chemical composition of 
individual monomers. Specifically, without changing the chemistry of the monomers of LiPCDA 




separation by removing a small molecule, that of water, that was incorporated into the crystal. The 
resulting 674LiPCDA is expected to have a similar dose response to PCDA: linear and less 














Chapter 2: Dosimetric evaluation of a modified 















2.1 Introduction to evaluation of modified EBT-3 
This chapter describes the effect of desiccating 635LiPCDA to 674LiPCDA on radiochromic 
film’s dosimetric behaviour. Because of the decrease in ∆ODnet  per dose, films composed of 
674LiPCDA should exhibit an increase in dynamic range compared to commercial EBT-3 film 
which has optimal signal response between 0.2Gy and 10Gy73.  An overlap in dynamic range may 
allow for a two-point verification of dose since the two crystal forms have separate absorbance 
peaks54. In this chapter, the methods used to investigate this hypothesis are described in detail.  
2.2 Materials and methods  
 
2.2.1 Solid WaterTM Phantom  
For real-time measurements, a custom 30 cm x 30 cm x 4 cm Solid WaterTM phantom, 
which has X-ray attenuation similar to that of water, and optical fiber read-out was used 74. The 
films were positioned in the center of the custom phantom with the centre of the film (and point 
of optical read-out) at 1.5 cm depth along the irradiation beam's central axis. Two removable 
optical fiber holders also made from Solid WaterTM were embedded in the phantom, holding the 
optical fibers at 1.5 cm depth in the phantom perpendicular to the film for transmission 
spectroscopy.  A ~50 cm (1500/1550 core-cladding diameter in µm, Thorlabs, Newton, NJ, USA) 
fiber is used to deliver light to the film and an identical fiber was used to collect transmitted light, 
as shown in Figure 4. The delivery and detection fibers have a non-connectorized bare fiber end 
inside the solid water phantom. In this configuration the light was transmitted from the delivery 
fiber through the film and collected by the detection fiber, in semi-free space; the holders were 
used to line up and inhibit motion in the system. The phantom allowed for replacement of film 




the same material. The film holder had a switchable component which could hold either one or 
two ~1 cm x 1 cm commercial films.  
 
Figure 4: Schematic diagram of the custom phantom showing the fiber and film holders embedded into the 
phantom, with delivery and detection fibers protruding from the phantom. A magnified view of the film 
holder demonstrates the light path through the sample film. 
2.2.2 Modification of EBT-3 film   
EBT-3 film is comprised of an active layer that is reported to be 27 µm thick sandwiched 
between two 120 µm transparent polyester substrates75. For a comparative investigation, both 




film (lot No. 03111902), cut into two halves. One half, was left unaltered and stored in a light safe 
box, acting as the reference sample of 635LiPCDA. The second half had one substrate layer peeled 
off to expose the radiochromic coating. The peeled film was then desiccated in an oven at 45°C 
with ~10 g of calcium chloride desiccant over ten days. This film is referred to as DesEBT-3. Both 
films were stored in a light safe box until exposure experiments with a LINAC. At the time of 
experiments, randomly selected segments ~1 cm x 1 cm were cut out of EBT-3 and DesEBT-3 
films for irradiation. This was done to avoid any coating biases such as minor differences in 
thickness of the film due to coating direction. 
2.2.3 Scanning Electron Microscope imaging 
To prepare the films for SEM imaging, a 5 cm x 5 cm (each subdivided further into ~ 1cm 
x 1cm pieces) film sample was cut from both the EBT-3 and DesEBT-3 films.  These were placed 
into separate beakers with ~30 ml of water. The beakers with the films were then put in a hot water 
bath at ~45°C (below the melting temperature of the crystal) and stirred for 2–3 hours. This process 
melted the binder material and separated the active component from the polyester substrate. The 
polyester pieces were picked out, and the remaining contents of each beaker were then poured onto 
filter paper (WhatmanTM, particle retention >11µm) and left in an open environment for 3–4 days. 
The polymer crystals of LiPCDA, which are water insoluble, were then scraped off the filter and 
placed onto SEM stubs for imaging.  Both 635LiPCDA and 674LiPCDA were imaged with a 
scanning electron microscope (SEM, QuantaTM, Thermo ScientificTM, Waltham, MA, USA) in a 
high vacuum and with an accelerating voltage of 10 kV.  
2.2.4 Dose delivery and ∆OD measurement   
For exposure experiments, the film samples were put inside the Solid WaterTM phantom. 




patient bed of a Varian True Beam linear accelerator (Varian Medical System, Palo Alto, 
California, USA). The film inside the phantom was positioned at the center of the beam using its 
crosshairs. All films were irradiated with a 6 MV beam under standard conditions (100 cm source-
to-axis distance, 10 x 10 cm field of view).  A range of doses between 50 –7000 cGy in total dose 
were delivered at 300 cGy/min. Five film samples were used from both EBT-3 and DesEBT-3 for 
every dose up to 3000 cGy. Only DesEBT-3 was exposed to doses greater than 3000 cGy.  
The light source used to measure radiation induced change in optical density was a broad 
spectrum (360–2400 nm) tungsten halogen source (5W HL-2000-FHSA, Ocean Optics Inc., 
Orlando, FL, USA). The light source was located outside of the radiation bunker and connected to 
a 17 m long fused silica fiber (600/630 µm core-cladding diameter, Thorlabs, Newton, NJ, USA). 
The long fiber was then then pulled through the radiation bunker and SMA connected to the 
delivery fiber. Another 17 m long fused silica fiber (600/630 µm core-cladding diameter, Thorlabs, 
Newton, NJ, USA) was SMA connected to the detection fiber and returned from the phantom to a 
spectrophotometer outside the bunker. The spectrophotometer used for detection was a 200–1100 
nm range CCD camera (USB4000, Ocean Optics, Orlando, FL, USA). The spectrometer 
integration time was varied between 10−80 ms, depending on the experiment; however, the 
frequency of spectra collection was maintained at ~1 Hz for all experiments. Post-exposure 
development experiments were completed by continuously measuring the absorbance spectra of 5 
film samples of each crystal form, for ~60 min after 200 cGy dose exposure. A schematic diagram 





Figure 5: Schematic diagram of the real-time X-ray exposure apparatus. The light to and from the phantom 
is transported through the radiation barrier through 17 m fused silica fibers. 
Spectral data were analyzed using a MatLab® based software. Transmitted light through 




irradiation was used as the background or reference spectrum. The ∆A was calculated as the log of 
the ratio of the light transmitted through the film sample before exposure and the transmitted light 
during and after exposure as described by equation 1.  





where 𝐼(𝜆)𝑟𝑒𝑓 is the background reference intensity collected before the X-ray beam was turned 
on, 𝐼(𝜆)𝑑𝑎𝑟𝑘 is the dark spectrum which accounts for stray light collected by the spectrophotometer 
with no interrogation light being allowed to reach the detector, and 𝐼(𝜆)𝑑𝑎𝑡𝑎 is the transmitted light 
intensity collected during and after exposure. The ∆OD, as shown in equation 2, is then calculated 
by integrating the absorbance 10 nm around the main absorbance peak of the sample film54,74 
where  𝜆𝑛 to  𝜆1 spans the 10 nm window. This averaging window was used to minimize the errors 
associated with λmax occurring at slightly different wavelengths due to system noise
28,32. 






) (𝜆𝑖+1 − 𝜆𝑖)
𝑛−1
𝑖=1    (2) 
 
A schematic plot in Figure 6 shows that the net optical density as a function of time can be broken 
up into three distinct sections: (a) pre irradiation, (b) during irradiation, and (c) post-irradiation. 
The ∆OD at end of radiation, marked by an abrupt change in ∆OD increase, is used to determine 
the comparative change in optical density with dose for each sample. The uncertainty in average 

















Figure 6: A model representation of the optical density change as a function of time. The irradiation 
is applied for a period of time depicted by segment (b). 
 
By plotting the ∆OD against total dose, calibration curves for both DesEBT-3 and EBT-3 were 
generated. The dose curves of each film around the main absorbance peak are expected to be a 
third order polynomial function40,76 of the form shown in equations 4 and 5, 
 ∆𝑂𝐷𝐷𝑒𝑠𝐸𝐵𝑇−3
𝜆𝑛−𝜆1 =  𝑝1(𝐷)3 +  𝑝2(𝐷)2 +  𝑝3(𝐷) + 𝑝4 (4) 
 ∆𝑂𝐷𝐸𝐵𝑇−3
𝜆𝑛−𝜆1 =  𝑝5(𝐷)3 +  𝑝6(𝐷)2 +  𝑝7(𝐷)  +  𝑝8 (5) 
  
where D is the total dose in cGy delivered and p1–p8 are coefficients determined experimentally 





The post-irradiation segment (c) depicts increased optical density growth between the time 
of irradiation completion and end of measurement. The percent increase in OD after the point of 
end of radiation is referred to as post-exposure kinetics and is used as a surrogate measure of 
kinetics during exposure. This is required because during a beam segment the propagation of 
polymers and initiation of new polymerization reactions are simultaneously taking place, both 
contributing to the increased optical density, with no way to separate the two without extensive 
modeling. Thus, the percent increase in OD was measured for ~1 h after exposure for both 
635LiPCDA and 674LiPCDA with five film samples each. Films were exposed to 200 cGy 
delivered with a 6 MV beam at 300 cGy/min, data was continually collected before, during, and 
~1 h after irradiation.  
2.2.5 Multifilm dose measurement  
 Since both 674LiPCDA and 635LiPCDA are dose sensitive and have spectrally resolvable 
absorbance peaks, a two-point verification of total dose delivered is possible. In a simplest 
iteration, both 635LiPCDA and 674LiPCDA can be placed in direct contact with each other in the 
film holder. In this case, they can be assumed to be at the same point in space for dose 
measurements and exposed to the same total dose. The light path is directed through both films 
from the delivery fiber to the detection fiber. Since the interrogation light travels through both 
films, the absorbance of each film is additive. Thus, the dose response or total change in optical 
density is give by equation 6,  











where the ∆𝑂𝐷𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝑡𝑜𝑡𝑎𝑙
𝜆𝑛−𝜆1  is the change optical density measured for the combined absorbance 
spectra calculated using equation 2.  Then by substituting the dose curves of each film shown in 
equation 4 and 5, the total dose is determined by solving the third order polynomial shown in 
equation 7. Solutions to equation 7 are then determined iteratively using the fitted coefficients. 
 0 = (𝑝5 + 𝑝1)(𝐷𝑜𝑠𝑒)3 + (𝑝6 + 𝑝2)(𝐷𝑜𝑠𝑒)2 
                              + (𝑝7 + 𝑝3)(Dose) − (∆𝑂𝐷𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝑡𝑜𝑡𝑎𝑙
𝜆𝑛−𝜆1 − 𝑝4 − 𝑝8) 
(7) 
   
The combined films were exposed to 100–3000 cGy using a 6MV beam at 300 cGy/min dose 
rate.  
2.2.6 Growing crystals of 674LiPCDA 
 LiPCDA monomers were also chemically varied by changing the concentration of Li+, to 
determine if a similar spectral shift would be observed. A concentration series of Li+ was prepared 
by varying the molar ratio of Li+ to PCDA from 0.2:1 to 1:1. Absorbance spectra after exposure to 
UV light were then measured, and SEM images of these formulations coated on to Mylar film 
were obtained.  
2.3 Results and discussion  
 
2.3.1 Comparison of absorbance 
Absorbance spectra of reference EBT-3 film and DesEBT-3 after 5 Gy dose are shown in 
Figure 7 and demonstrates that most, or all, of 635LiPCDA crystals have been converted to the 
674LiPCDA form. The fraction of water removed from the film through desiccation was not 
quantified. The peak absorbance for reference EBT-3 film occurred at the expected wavelength of 




similar to PCDA28,63; however, the peak absorbance was much lower in comparison to 
635LiPCDA.  
 
Figure 7: Change in absorbance of DesEBT-3 (674LiPCDA) and reference EBT-3 (635LiPCDA) film. 
Films were exposed with a 6MV x-ray beam at a rate of 300 cGy/min to a total dose 500 cGy. 
This confirms that the commercial EBT-3 film consisting of 635LiPCDA crystals can be reliably 
converted to the 674LiPCDA form through desiccation. The shift in absorbance spectra indicates 
that the molecular electronic configuration has changed and that removal of water had caused a 




Absorbance spectra of formulated crystals showed, that a 1:1 ratio of Li+ to PCDA resulted 
in a LiPCDA polymer, which has absorbance spectrum similar to 674LiPCDA. In contrast, a 0.2:1 
stoichiometric ratio has a spectrum like that of 635LiPCDA. This suggests that in 635LiPCDA of 
commercial EBT films is likely a mixture of Li+ and H+ associated diacetylene monomers. 
2.3.2 Macroscopic crystal structure comparison  
It has been shown that 674LiPCDA crystals can be grown instead of being produced 
through the conversion of 635LiPCDA54. When the 674LiPCDA crystals are grown, they 
demonstrate a “plate-like” structure with an aspect ratio less than 2:1, similar to PCDA. However, 
when the 635LiCPDA crystals present in EBT-3 films were desiccated and demonstrated a spectral 
shift, their crystal morphology did not show any notable difference compared to the un-desiccated 
635LiPCDA crystals. The 674LiPCDA produced through desiccation maintained an aspect ratio 
greater than 10:1. Electron micrographs (Figure 8) show a qualitative comparison of the overall 
structures at 2500x magnification and 10.00 kV accelerating voltage. The 674LiPCDA crystals 
maintain their shape and size, with no notable fragmentation due to the desiccation even when 
viewed at 25,000x magnification. This suggests that the absorbance shift is likely due to changes 
in the molecular packing of the monomers at the microscopic scale, which does not alter the 
macroscopic crystal structure. In contrast, SEM images of formulated crystals (Figure 9) show 
different crystal morphologies, where the 1:1 LiPCDA (absorbance peak at 674 nm) is “plate-like” 
and the 0.2:1 LiPCDA (absorbance peak at 635 nm) has a “hair-like” crystal morphology. This 






Figure 8: SEM images of DesEBT-3 (674LiPCDA) (left) and EBT-3 (635LiPCDA) (right) with binder 
removed. Images were taken at 2500x magnification. 
 
Figure 9: SEM images of “plate like” LiPCDA (left) and “hair-like” LiPCDA (right). Images were 
taken at 9000x and 10000x magnification for “plate-like” and “hair-like”, respectively. 
In a recently published thesis77, thermogravimetric analysis and solid state NMR results showed 
that the 635LiPCDA is a LiPCDA monohydrate while 674LiPCDA is anhydrous LiPCDA. This 





2.3.4 Evaluation of dose-response of DesEBT-3  
674LiPCDA obtained through desiccation has dose sensitivity ~3x lower than commercial 
635LiPCDA. The ∆ODnet against dose is shown in Figure 10 and Table 2 contains a summary of 
the percent standard deviation based on five separate samples for each film at all nominal total 
doses. When commercial EBT-3 films were exposed to doses >20 Gy, a diminished ∆ODnet was 
observed as absorbance started to reach the saturation limits of the spectrophotometer (∆OD > 
2.5). It was expected that 674LiPCDA films would have a linear dose response similar to PCDA, 
up to 6 Gy using the main absorbance peak (λmax = 676 nm)
63 however, no linear dose response 
was observed between 0-70 Gy. The lower dose response of 674LiPCDA films allowed for signal 
detection at higher doses, up to 70 Gy and potentially higher. The high uncertainty (%σ standard 
deviation) measured for DesEBT-3 may be due to the incomplete desiccation of 635LiPCDA.  
A shift in λmax for 674 LiPCDA (Figures 11 and 12) was observed with increasing dose. 
This shift from 677 ± 1.1 nm to 674 ± 0.5 nm occurred when 674LiPCDA was exposed to doses 
>500 cGy. In contrast, 635LiCPDA maintained a constant λmax up to the saturation limit of 2000 
cGy. The shift in λmax indicates that the polymer may have undergone a reorientation and that the 
monomers in 674LiPCDA are not in their most stable configuration. Thus, as the dose is increased, 







Figure 10: ∆OD as a function of dose for EBT-3 (635LiPCDA) and DesEBT-3 (674LiPCDA) films. EBT-
3 films were exposed to 50–3000 cGy, reaching detection limits between 2000–3000 cGy. DesEBT-3 films 
were exposed up to 7000 cGy, 
Table 2: Percent standard deviation (%σ) of dose measurement with N=5 independent samples. 
Dose (cGy) 50 100 200 500 1000 2000 3000 4000 5000 7000 
%σ EBT3 1.4 0.7 0.4 0.8 0.6 0.2 0.4 - - - 
%σ Des 
EBT3 





Figure 11: Sample absorbance spectra of 635LiPCDA (top) and 674LiPCDA (bottom) with vertical 






Figure 12: Wavelength at peak absorbance against total dose delivered, N=5 film samples were 
exposed for each nominal dose. Error bars represent 1σ standard deviation. Inset figure shows the 
initial decrease in λmax with dose of DesEBT-3. 
2.3.5 Post-exposure response  
The post-exposure continual development of radiochromic film is a potential point of 
concern for real-time dosimetry28,60.  Due to difficulties in teasing out this information during 
irradiation, this is assessed by measuring the extent of OD increase after end of exposure as a 
function of time28.  Figure 13 shows the percent increase in OD over time after exposure to 200 





Figure 13: Percent post-exposure OD increase for N=1 sample, exposed with a 6 MV beam to 200 
cGy at a 300 cGy/min. Data was continually collected for ~1 h after exposure. 
A summary of the post-exposure percent increase in OD for both films, along with p-
values, are shown in Table 3. Results show an average (N=5 independent samples) of 5.0 ± 0.1 % 
increase in OD after 1 min and 29.2 ± 0.3% after 60 min following exposure for 635LiCPDA, 
while the 674LiPCDA had a 3.7 ± 0.1 % at 1 min and 25.2 ± 3.8 % after ~1 h. A t-test to compare 
means at ~1 h with α = 0.05 resulted in a two tailed p-value > 0.05, indicating that the post-exposure 
kinetics of 635LiCPDA and 674LiPCDA are not significantly different at 1 h. However, at times 




polymerization kinetics of the 674LiPCDA may be faster than 635LiPCDA. This was an 
unexpected result given that 635LiPCDA previously showed faster polymerization than PCDA30 
and we believed PCDA to pack similarly as desiccated LiPCDA. To make a definitive conclusion, 
repeat post-exposure data needs to be collected over a longer period of time (>1 h). A high amount 
of uncertainty (%σ standard deviation) was recorded for average %OD increase for DesEBT-3, 
possibly due to incomplete desiccation as previously mentioned.  
Table 3: Post-exposure kinetics of both 635LiPCDA and 674LiPCDA with N=5 samples averaged at 
specific time points after exposure. P-value indicates the statistical difference in %OD increase between 
both film formats for each time point (α =0.05) 
Time 
(min) 
<%OD increase>  
EBT-3 
<%OD increase>  
DesEBT-3 
P-Value 
1 5.0 ± 0.1 3.8 ± 0.1 5.9 x10-7  
5 13.3 ± 0.3 9.6 ± 0.6  2.6 x10-5  
10 18.2 ± 0.4  12 ± 1 2.4 x10-4 
15 21.1 ± 0.5 15 ± 2 5.7 x10-4 
30 25.7 ± 0.6 20 ± 3 6.5 x10-3 
60 29.9 ± 0.6 26 ± 4 9.7 x10-2 
 
2.3.5 Clinical application   
A radiochromic probe dosimeter for real-time in vivo use needs to be sensitive to low dose, 
as described in Table 1. But ideally it would also have a dynamic range above 10 Gy for 
applications in brachytherapy which can have prescribed doses of 13–19 Gy, and hyper doses of 
200–400% of that. In stereotactic radio surgery, the prescribed dose per fraction can be 8–30 Gy78. 
Since 635LiPCDA radiochromic dosimeters have a dynamic range of 0.1–20 Gy, depending on 
the spectral range being used, this material alone is limited to only some applications. A potential 
novel way to increase the dynamic range of a radiochromic fiber optic probe dosimeter is to use 




films and independent films are shown in Figure 14. This combined dosimeter can potentially have 
the high dose sensitivity of 635LiPCDA at low doses and extend the dynamic range with 
674LiPCDA above 20 Gy.  
 
Figure 14: Absorbance spectra of combined 635LiPCDA and 674LiPCDA films (solid) and 
independent measures of 635LiCPDA (dash) and 674LiPCDA (dash-dot) after exposure to 500 cGy 
with a 6 MV beam at a 300 cGy/min. 
The algorithm described in section 2.6 for multi-film measurements was able to determine 
the true dose delivered up to 500 cGy within 1% error, when using the 630−640 nm absorbance 




underreport dose due to the detector saturation for combined 635LiPCDA and 674LiPCDA in this 
part of the spectrum. To report dose more accurately above 500 cGy using two films, the 
wavelength range was shifted to 670–680 nm which is ~10 nm around the peak absorbance of 
674LiPCDA. When using the 670–680 nm absorbance range to determine the ∆OD, it was found 
that the polynomial coefficients p1 and p2 shown in equation 6 tend to 0 (𝑝1 → 0, 𝑝2 → 0). Thus, 
in the absorbance window of 670–680 nm the dose response of 635LiPCDA was reduced to a 
linear function of the form shown in equation 8.  
 ∆𝑂𝐷𝐸𝐵𝑇−3
630−640 =  𝑝1(𝐷)
3 +  𝑝2(𝐷)
2 +  𝑝3(𝐷)  +  𝑝4 (8) 
 ∆𝑂𝐷𝐸𝐵𝑇3
670−680 =  𝑝5(𝐷)  +  𝑝6 (9) 
 ∆𝑂𝐷𝐷𝑒𝑠𝐸𝐵𝑇−3
630−640 =  𝑝7(𝐷)
3 +  𝑝8(𝐷)
2 +  𝑝9(𝐷)  +  𝑝10 (10) 
 ∆𝑂𝐷𝐷𝑒𝑠𝐸𝐵𝑇−3
670−680 =  𝑝11(𝐷)
3 +  𝑝12(𝐷)
2 +  𝑝13(𝐷)  +  𝑝14 (11) 
Where 𝑝5 and 𝑝6 are determined by curve fitting a linear regression on to the dose against ∆OD 
data. Table 4 contains a summary of calculated dose using different spectral bands against the 
actual dose delivered. The percent differences between reported dose and true dose delivered are   
< 5% for the 1000–3000 cGy using equations 9 and 11.  
Table 4: Summary of calculated dose and percent difference to the actual dose delivered. 
Delivered 
Dose (cGy) 









100 100.8 0.8 81.9 18.1 
500 504.3 0.9 566.8 13.4 
1000 863.0 13.7 1031.0 3.1 
2000 `1281.7 35.9 2075.5 3.8 





These results show that a radiochromic dosimeter using both crystal forms of LiPCDA 
(635LiPCDA and 674LiPCDA) can measure dose as low as 100 cGy with <1 % difference, and 
probably lower40, although not confirmed in these sets of experiments. However, the spectral 
window needs to be shifted to 670-680 nm to measure doses >500cGy with a <5% difference. For 
doses >3000 cGy this algorithm for calculated dose, regardless of which wavelength window is 
used, may not be valid. This is because the percent difference between delivered and calculated 
dose demonstrated an increasing trend with dose. To ensure that the dynamic range of the 
combined measurements can be extended, further testing is needed.  
2.4 Conclusions on modified EBT-3 
The 674LiPCDA produced through desiccation of commercial EBT-3 film was observed 
to be structurally indistinguishable with SEM from the native form but turned out to be ~3x less 
sensitive to dose resulting in a higher dynamic range. Although 674LiPCDA did share λmax with 
PCDA ~675 nm, it was not observed to produce a linear dose response over a similar range28. The 
635LiPCDA, which is specified to be sensitive between 10–2000 cGy as reported by its 
specifications79, caused the radiochromic optical sensor to reach saturation ∆OD >2.5 when 3000 
cGy was delivered. In contrast, the 674LiPCDA film produced a detectable signal response up to 
7000 cGy while being below the saturation limits of the optical system and above detection limits 
of the transmitted photons. Despite having a lower sensitivity and larger dose sensitive range 
674LiPCDA crystals showed no statistical difference in post-exposure kinetics when compared to 
635LiPCDA at 1 h. However, at time intervals <1 h 635LiPCDA had higher percent increase in 
OD relative to 674LiPCDA, requiring further testing over a longer time range in order to validate 
difference in relative reaction rates. These differences in dosimetric behaviour between 




Specifically, the desiccation altered the packing structure of the monomers by removing enough 
water molecules to change the separation distance between monomers, resulting in a different dose 
response. This shows that the dosimetric behaviour of radiochromic crystals, which is dependant 































3.1 Conclusions  
In this thesis it was hypothesized that the dosimetric behaviour of radiochromic crystals is 
primarily dependent on structure, which may be a function of more than just the chemical 
composition of individual monomers. Specifically, without changing the chemistry of the 
monomers of LiPCDA the dose response may still be altered through a difference in packing 
structure and monomer separation through use of small molecules, such as water. In this research 
the dosimetric behaviour of the two dose sensitive forms of LiPCDA (635LiPCDA and 
674LiPCDA produced by desiccating 635LiPCDA) were compared. It was found that 674LiPCDA 
was comparatively lower in dose sensitivity and had different polymerization kinetics and an 
extended dynamic range, suggesting that removal of water had actually altered the packing and 
suggesting that water forms a cocrystal with the radiochromic monomers. 674LiCPDA was shown 
to be a viable radiochromic dosimeter for potential use in real time in vivo dosimetry. It was also 
demonstrated that a dose measurement can be performed using both 635LiPCDA and 674LiPCDA 
simultaneously within a single fiber-optic path. While the combined sample showed dose 
sensitivity similar to 635LiPCDA at doses <500 cGy, an increasing trend in % difference between 
the calculated and the delivered dose was observed, and further testing is needed to report dose 
>3000 cGy. A combined film consisting of both 635LiPCDA and 674LiCPDA can be used as the 
dose sensitive component of a fiber optic probe dosimeter, taking advantage of both crystal forms.  
3.2 Future Directions: Dose rate characterizations of 674LiPCDA 
For applications in real-time in vivo dosimetry, any uncertainties in the real time dose 
measurement of the 674LiPCDA need to be characterized.  One of these uncertainties is due to 
variable darkening of the film as a function of continuous dose deposition. This is because during 




finite time to form.  At higher dose rates, this lag in polymer formation causes a lower ∆OD than 
expected. The post-exposure ∆OD of radiochromic film is a surrogate for the delay in polymer 
completion that occurs during exposure, and has been shown to be related to the dose rate28,32. The 
∆OD of 635LiPCDA has been shown by Rink et al.40 to have a percent standard deviation < 4.5% 
in ∆OD measurements from 16−520 cGy/min. Thus, a future hypothesis to test would be, 
674LiPCDA has a dose rate dependence similar to 635LiPCDA and its rate of ∆OD increase is not 
proportional to the dose rate.  
3.3 Future directions: Varying Li+ molar ratio in LiPCDA to produce crystal 
mixtures  
It was demonstrated in this thesis that a fiberized dosimeter configuration produced by 
combing the two radiochromic films 635LiPCDA and 674LiPCDA could potentially allow for an 
increased dynamic range while maintaining dose sensitivity down to 5 cGy as previously shown 
for EBT films40. This was done by simply stacking two films. Another potential way of using both 
635LiPCDA and 674LiPCDA is to grow both crystals simultaneously in solution, and make 
coatings using the mixture for use as a dosimeter. This can be achieved by varying the molar ratio 
Li+ to PCDA, where crystals that appear to have both the Li+ and H+ bonded monomers would have 
peak absorbance at 635 nm and crystals that have mostly Li+ bonded monomers would have peak 
absorbance at 674 nm. Thus, it is expected that by increasing the Li+ concentration the dominant 
crystal form can be shifted from 635LiPCDA to 674LiPCDA and at some molar ratio of Li+: PCDA 
both crystal forms will be present. Preliminary investigations support this hypothesis and have 
demonstrated that radiochromic crystals with both absorbance peaks (~635 nm and ~674 nm) can 
be obtained at 0.6:1 stoichiometric ratio of Li+ to PCDA. Figure 15 shows the absorbance spectra 




increases, the 635 nm peak maximum shrinks in intensity, while the 674 nm peak grows. Figure 
16 shows the resultant SEM image of the 0.6:1 Li+ to PCDA crystal structure at 3500x 
magnification with both “plate-like” and “hair-like” crystals present.  
 
Figure 15: Varying molar ratio of Li+ to PCDA solutions, exposed with UV light to produce 
absorbance spectra. No thickness correction was applied.  
The data shows that not only are both absorbance peaks present at this ratio, but both 
macroscopic crystal structures are also present. By further investigating absorbance peaks of the 
Li+ concentration series between molar ratios ranging from 0.6:1 to 0.9:1 an optimal molar ratio 
can be determined. An ideal mixture of crystals would have a sufficient absorbance signal from 




optimized mixture would have low dose sensitivity due to the 635LiPCDA and the dynamic range 
of the 674LiPCDA. 
  
Figure 16: SEM image of a 0.6:1 ratio of Li+ to PCDA mixture which had absorbance peaks at 635 nm and 
674 nm. Image was taken at 3500x magnification. 
3.4 Future directions: A two-point verification of dose from spatially separated 
films  
Secondary simultaneous verification of dose from a different location of the same optical 
fiber dosimeter increases the measurement's confidence and provides extra information about the 
dose distribution. This is not possible when using just one form of LiPCDA as multiple films of 
the same form would not provide any unique information. When two forms of LiPCDA 




occurring at the expected ~635 nm and ~674 nm wavelengths. These two peaks are ~40 nm apart, 
sufficiently spaced to allow for a 10 nm integration window around each peak to determine the 
∆ODnet signal for each film. In the configuration described in this thesis, the radiochromic 
dosimeter is able to measure dose from a single point in space. Therefore, by measuring the true 
dose delivered at multiple points during a treatment the confidence of the measured dose increases. 
With multiple spatially separated film formats such as 635LiPCDA and 674LiPCDA it is possible 
to measure the dose at two points of interest in real time through a single dosimeter. The dose 
would then be determined by solving the system of equations 12–16, where D1 and D2 is the dose 









630−640 =  𝑝1(𝐷1)
3 +  𝑝2(𝐷1)
2 +  𝑝3(𝐷1) + 𝑝4 (13) 
 
∆𝑂𝐷𝐸𝐵𝑇3
630−640 =  𝑝5(𝐷2)
3 +  𝑝6(𝐷2)
2 +  𝑝7(𝐷2)  +  𝑝8 (14) 
 
∆𝑂𝐷𝐷𝑒𝑠𝐸𝐵𝑇3
670−680 =  𝑝9(𝐷1)
3 +  𝑝10(𝐷1)
2 +  𝑝11(𝐷1) + 𝑝12 (15) 
 
∆𝑂𝐷𝐸𝐵𝑇3
670−680 =  𝑝13(𝐷2)
3 +  𝑝14(𝐷2)
2 +  𝑝15(𝐷2)  +  𝑝16 (16) 
 
Unlike in the example used in Section 2.3.5, in this configuration the dose absorbed by 
each film would not be the same. The absorbance spectra from the spatially separated films are 
expected to be similar to Figure 14, as this would also be the combined absorbance of 635LiPCDA 
and 674LiPCDA.  The polynomial fitting coefficients p1 –p16 are determined by fitting in a similar 
process described in section 2.2.5 To validate this method of measuring dose distributions in real 
time an apparatus to hold two film holders was designed and prototyped to fit within the existing 
phantom. Future work will look to design and build a phantom that can accommodate two film 




delivered dose to reported dose. For dose distribution measurements the films would be placed in 
their own individual film holders with interrogation light travelling through each film before 
detection at the spectrophotometer. A schematic representation of this configuration is shown in 
Figure 17.  
 
Figure 17 Schematic diagram of a spatially separated film measurement. 
 
3.5 Future directions:  Integrating an IR calibration dye into a fiber optic probe 
dosimeter 
 In recent years commercial Gafchromic®  films have been used for real-time readout of 
dose80,81. To meet the recommendation set by IEAE for in vivo dosimetry, a fiber optic probe 
dosimeter based on radiochromic materials was designed and fabricated by Rink et al.82,83.  One 
of the challenges of fabricating a miniature dosimeter with micron-thick coating is the 
reproducibility and uncertainty in the coating itself. For a given radiochromic formulation, film 
sensitivity is dependent on the monomer packing and the coating thickness.  Future work will focus 
on optically calibrating for the thickness of radiochromic material, and thus accounting for 
sensitivity of any individual probe. In our approach, calibration will be performed through a 
homogeneously incorporated infra-red (IR) dye in the radiochromic film. A homogeneously 
dispersed IR dye can be used to measure the thickness of the film given a priori knowledge of the 
concentration, extinction coefficient, and peak absorbance of the dye, according to the Beer- 




the amount of radiochromic material for a given formulation. An IR dye is needed in order to avoid 
interference (spectral overlap) with the absorbance spectrum of the radiochromic material. Also 
since optical fibers are poor transmitters of UV/blue light, IR wavelengths are better suited as the 
calibration dye for optimal fiber optic signal transmission.  Furthermore, fibers that transmit in the 
IR are also more ubiquitous and cheaper than alternatives, such as those in the UV. Figure 18 
shows a schematic diagram of a previously developed fiber optic probe dosimeter with an IR dye 
incorporated into the coating and preliminary absorbance spectra collected upon UV exposure. 
Our previously designed and developed probe prototypes utilized plastic optical fibers, a thin film 
of LiPCDA and a dielectric mirror for transmission-reflection spectroscopy as shown in Figure 18. 
In this reflection mode configuration, the interrogation light would travel through the radiochromic 
film twice before reaching the detector. Preliminary coatings of 635LiPCDA and IR-783 dye were 
made. Both absorbance peaks from the radiochromic material and IR dye (the latter shifted from 
783 nm to 800 nm in radiochromic suspension) were observed using a Cary 500 
spectrophotometer. The absorbance peak of IR-783 was stable with increased UV exposure as 
shown by Figure 18, confirming that is does not degrade with UV radiation exposure. Since the 
IR-783 dye absorbance peak is stable with radiation exposure, only a simple background 
subtraction of the IR dye absorbance in the 630-640 nm band is needed to measure the change in 
absorbance from the radiochromic material. Future work will determine the optimal concentration 
of IR dye needed to produce an absorbance signal of ~0.5, needed for sufficient signal to noise 
ratio to measure submicron film thickness. Next, calibration curves of absorbance against 
thickness will be produced and used to characterize the dose response of the combined formulation. 
These future steps will allow for thickness dependent sensitivity calibration of the radiochromic 






Figure 18: Schematic of optical dosimeter probe construction with dye-integrated radiochromic film84 
With preliminary data showing change in absorbance of LiPCDA coatings on Mylar™ substrate with 




3.6 Summary  
In this thesis the dosimetric behaviour of desiccated 635LiPCDA (674LiPCDA) was 
investigated and compared to 635LiPCDA. It was found that 674LiPCDA had ~3x lower dose 
sensitivity, a dynamic range up to 7000 cGy and faster post-exposure kinetics relative to 
635LiPCDA. 674LiPCDA was also non-linear in dose response similar to 635LiPCDA. These 
findings support the hypothesis that the monomer packing of radiochromic crystals and dosimetric 
behaviour is more than just a function of their chemical composition, modifiable through use of 
small molecules, such as water, incorporated into the crystal structure. In terms of clinical 
applications, 674LiCPDA can be used in combination with 635LiCPDA to produce an in vivo real-
time dosimeter with simultaneously high dose sensitivity and high dynamic range.  Future work 
will continue to develop combined films and integrate an IR dye into the radiochromic probe 
dosimeter developed by Rink et al.82,83. The integration of the IR-dye will fulfill the requirement 
for sensitivity calibration measurements done by to measuring the amount of radiochromic 
material before a treatment. While this work showed an important understanding, that the 
dosimetric behaviour of the radiochromic film can be manipulated without changing the monomer 
chemistry, future work remains to be done as described here. Translational studies are also 
currently underway towards the development of an optimal radiochromic probe dosimeter 
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A: Fundamental interactions of ionizing radiation with matter  
Photoelectric effect, incoherent Compton scattering, and pair/triplet production are the 
photon attenuation mechanisms relevant to radiotherapy. Each of these mechanisms may occur 
individually or as a combination, though each mechanism has a range of energy and atomic number 
combinations in which it is the dominant method of photon attenuation, as shown in Figure A.1. 
Film samples of EBT-3 used in this thesis were irradiated with a 6 MV beam and had Zeff = 7.26
29, 
which is within the Compton dominant region. Thus, photoelectric and pair/triplet production are 
considered to be negligible to the photon attenuation within these film samples.  
 
Figure A.1: Three main regions of high energy photon and matter interaction represented in terms of photon 







In Compton scattering the incident photon interacts with an orbital or free electron 
imparting a portion of its energy to the electron as an inelastic collision, conserving energy, and 
momentum85. The photon is deflected through an angle θ with respect to its initial trajectory and 
has a lower energy as shown in Figure A.2. The electron known as a secondary electron, receives 
the difference in energy between the incident and scattered photon as kinetic energy and is ejected 
from the orbital. The secondary electron then deposits its energy into the surrounding matter along 
its trajectory through atomic excitations and ionizations as it slows down within the medium. Most 
of the dose is deposited into the medium by the secondary electrons.   
 
Figure A.2: Compton scattering occurring on a valence electron of a carbon atom. The scattered photon 




B: UV-Vis Spectroscopy  
 The absorption spectra observed in radiochromic materials such as LiPCDA are due to the 
overlapping π orbitals or conjugated π bonds of the carbon backbone. When a photon with 
sufficient energy interacts with the electrons in the highest occupied molecular orbital (HOMO) 
of these π bonds, the photon energy is absorbed by the electron86. The electron is then promoted 
to the lowest unoccupied molecular orbital (LUMO) of a higher energy state, π*. This promotion 
is referred to as a π to π* electronic transition87.  The amount of energy needed to excite a π orbital 
electron is equivalent to the difference in energy (∆E) between the HOMO and LUMO states. 
However, with increasing π conjugations, the ∆E between these states decreases. Then as lower-
energy light is absorbed to promote electrons in systems with high π conjugated bonds, the peak 
absorbance λmax increases following the relation ∆𝐸 =
ℎ𝑐
𝜆
. An energy diagram representation of the 
HOMO-LUMO transition and ∆E with increasing conjugation is shown in Figure B.1. The peak 
absorbance of LiPCDA occurs at 635 nm indicating a high number of π bond conjugations; the 
overall spectra however is the average of many energy states and conjugation lengths.  
 
Figure B.1: Energy diagram of the HOMO-LUMO states and visual representation of the amount of 




The dose-response of radiochromic film is measured as the change in absorbance (∆A) at a 
particular wavelength, typically the λmax. The ∆A in an ideal no-noise system is simply defined as 
the log ratio of the initial light intensity (I(λ)0) against the transmitted light intensity (I(λ)) as shown 
by equation B.1. It is assumed that for radiochromic films, the only significant light attenuation is 
due to absorption, and attenuation from light scattering and reflection is negligible88. The (I(λ)0) is 
equivalent to the transmitted light through a film sample before exposure, in this case a film sample 
is used as its own reference measurement and light loss through the system can be ignored. 





The change in optical density (∆OD) is then defined as the definite integration of the average 
absorbance using an absorbance window 10 nm around λmax, as shown in equation B.2.  






) (𝜆𝑖+1 − 𝜆𝑖)
𝑛−1
𝑖=1    (B.2) 
 
The dose is then defined as the ∆OD at the end of irradiation, marked by an abrupt change in the 
rate of ∆OD. Once the irradiation is turned off, no new polymer reactions are taking place and any 
continued increase in absorbance is purely due to the formation of polymers of appropriate length 







C: Film thickness measurement  
The overall radiation sensitivity of radiochromic films is not only dependent on the 
particular monomer spacing as discussed in this thesis, but also on the amount of active material 
present in the film. A future direction described in this thesis (Ch 3.5) is to use micron thick 
radiochromic films integrated in an optical fiber as a dosimeter. The reproducibility of the films 
adds a source of uncertainty impacting the sensitivity of the radiochromic films. A simple way to 
account for small variations in film thickness is through the Beer-Lambert law, A=εcl (Equation 
C.1) with a priori knowledge of the concentration of absorber and its molar absorptivity along 
with measured absorbance.  
 
Figure C.1: Schematic diagram of light attenuation through a medium  
 𝐴 = 𝑙𝑜𝑔10 (
𝐼0
𝐼
) =  𝜀𝑐𝑙 (C.1) 
where I0 is the initial light intensity, I is the transmitted light intensity, ε is the molar absorptivity, 
c is the molar concentration, and l is the path length. 
 It is assumed that the absorber is homogeneously integrated through the radiochromic 
coating (Figure C.1), and that the light attenuation of the absorber is primarily due to absorbance 
and the effects from scattering and reflection are negligible. Using this absorber, known ε and c of 
that absorber for the batch, and measured A for an individual probe, the pathlength of the 
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